Subsequent events (Details) - Jul. 07, 2023 - Janssen $ in Thousands, € in Millions |
EUR (€) |
USD ($) |
|---|---|---|
| Disclosure of non-adjusting events after reporting period [line items] | ||
| Deal value | € 2,700.0 | |
| Top of Range | ||
| Disclosure of non-adjusting events after reporting period [line items] | ||
| Potential development and commercial milestones payments | $ | $ 650,000 | |
| Collaboration agreement, compensation per indication | $ | 220,000 | |
| Nanobiotix Corp. | Top of Range | ||
| Disclosure of non-adjusting events after reporting period [line items] | ||
| Collaboration agreement, compensation per indication | 220.0 | $ 220,000 |
| Major ordinary share transactions | ||
| Disclosure of non-adjusting events after reporting period [line items] | ||
| Deal value | 2,600.0 | |
| Potential development and commercial milestones payments | € 105.0 |